Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

References for PMC Articles for PubMed (Select 20453537)

1.

A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.

Perlis RH, Smoller JW, Ferreira MA, McQuillin A, Bass N, Lawrence J, Sachs GS, Nimgaonkar V, Scolnick EM, Gurling H, Sklar P, Purcell S.

Am J Psychiatry. 2009 Jun;166(6):718-25. doi: 10.1176/appi.ajp.2009.08111633. Epub 2009 May 15.

2.

Genetic predictors of response to antidepressants in the GENDEP project.

Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, Zobel A, Czerski PM, Larsen ER, Souery D, Giovannini C, Gray JM, Lewis CM, Farmer A, Aitchison KJ, McGuffin P, Craig I.

Pharmacogenomics J. 2009 Aug;9(4):225-33. doi: 10.1038/tpj.2009.12. Epub 2009 Apr 14.

PMID:
19365399
3.

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.

Need AC, Keefe RS, Ge D, Grossman I, Dickson S, McEvoy JP, Goldstein DB.

Eur J Hum Genet. 2009 Jul;17(7):946-57. doi: 10.1038/ejhg.2008.264. Epub 2009 Jan 21.

4.

A systematic method for estimating individual responses to treatment with antipsychotics in CATIE.

van den Oord EJ, Adkins DE, McClay J, Lieberman J, Sullivan PF.

Schizophr Res. 2009 Jan;107(1):13-21. doi: 10.1016/j.schres.2008.09.009. Epub 2008 Oct 18.

5.

Pharmacogenetics in drug discovery and development: a translational perspective.

Roses AD.

Nat Rev Drug Discov. 2008 Oct;7(10):807-17. doi: 10.1038/nrd2593. Epub 2008 Sep 19. Review.

PMID:
18806753
6.

Rapid cycling bipolar disorders in primary and tertiary care treated patients.

Hajek T, Hahn M, Slaney C, Garnham J, Green J, Růzicková M, Zvolský P, Alda M.

Bipolar Disord. 2008 Jun;10(4):495-502. doi: 10.1111/j.1399-5618.2008.00587.x.

7.

Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.

Perlis RH, Moorjani P, Fagerness J, Purcell S, Trivedi MH, Fava M, Rush AJ, Smoller JW.

Neuropsychopharmacology. 2008 Nov;33(12):2810-9. doi: 10.1038/npp.2008.6. Epub 2008 Feb 20.

8.

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.

Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S.

Biol Psychiatry. 2008 Jun 15;63(12):1103-10. doi: 10.1016/j.biopsych.2007.10.026. Epub 2008 Jan 11.

9.

Measuring depression: comparison and integration of three scales in the GENDEP study.

Uher R, Farmer A, Maier W, Rietschel M, Hauser J, Marusic A, Mors O, Elkin A, Williamson RJ, Schmael C, Henigsberg N, Perez J, Mendlewicz J, Janzing JG, Zobel A, Skibinska M, Kozel D, Stamp AS, Bajs M, Placentino A, Barreto M, McGuffin P, Aitchison KJ.

Psychol Med. 2008 Feb;38(2):289-300. Epub 2007 Oct 9.

PMID:
17922940
10.

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression.

Laje G, Paddock S, Manji H, Rush AJ, Wilson AF, Charney D, McMahon FJ.

Am J Psychiatry. 2007 Oct;164(10):1530-8.

PMID:
17898344
11.

Genomics and the future of pharmacotherapy in psychiatry.

Malhotra AK, Lencz T, Correll CU, Kane JM.

Int Rev Psychiatry. 2007 Oct;19(5):523-30. Review.

PMID:
17896232
12.

Translating pharmacogenomics: challenges on the road to the clinic.

Swen JJ, Huizinga TW, Gelderblom H, de Vries EG, Assendelft WJ, Kirchheiner J, Guchelaar HJ.

PLoS Med. 2007 Aug;4(8):e209. Review.

13.

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.

Paddock S, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ.

Am J Psychiatry. 2007 Aug;164(8):1181-8.

PMID:
17671280
14.

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW.

Arch Gen Psychiatry. 2007 Jun;64(6):689-97.

PMID:
17548750
15.

A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder.

Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nöthen MM, Georgi A, Schumacher J, Schwarz M, Abou Jamra R, Höfels S, Propping P, Satagopan J, Detera-Wadleigh SD, Hardy J, McMahon FJ.

Mol Psychiatry. 2008 Feb;13(2):197-207. Epub 2007 May 8.

16.

Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.

Garnham J, Munro A, Slaney C, Macdougall M, Passmore M, Duffy A, O'Donovan C, Teehan A, Alda M.

J Affect Disord. 2007 Dec;104(1-3):185-90. Epub 2007 Apr 17.

PMID:
17442400
17.

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.

McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papanicolaou GJ, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H.

Am J Hum Genet. 2006 May;78(5):804-14. Epub 2006 Mar 20.

18.

Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME.

Am J Psychiatry. 2006 Feb;163(2):217-24.

PMID:
16449474
19.

Pharmacogenomics and the drug discovery pipeline: when should it be implemented?

Penny MA, McHale D.

Am J Pharmacogenomics. 2005;5(1):53-62. Review.

PMID:
15727489
20.

Pharmacogenetics of antipsychotic-induced weight gain.

Correll CU, Malhotra AK.

Psychopharmacology (Berl). 2004 Aug;174(4):477-89. Epub 2004 Jul 8. Review.

PMID:
15243737
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk